INVITAE CORP's ticker is NVTA and the CUSIP is 46185L103. A total of 287 filers reported holding INVITAE CORP in Q3 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $26,157 | -46.8% | 43,220 | -0.6% | 0.00% | 0.0% |
Q2 2023 | $49,134 | -27.5% | 43,481 | -13.4% | 0.00% | -50.0% |
Q1 2023 | $67,744 | -32.8% | 50,181 | -7.4% | 0.00% | -33.3% |
Q4 2022 | $100,777 | -31.4% | 54,181 | -9.6% | 0.00% | -40.0% |
Q3 2022 | $147,000 | +77.1% | 59,903 | +76.2% | 0.01% | +66.7% |
Q2 2022 | $83,000 | -69.8% | 34,006 | -1.3% | 0.00% | -62.5% |
Q1 2022 | $275,000 | -29.7% | 34,460 | +34.7% | 0.01% | -27.3% |
Q4 2021 | $391,000 | -69.5% | 25,591 | -43.3% | 0.01% | -73.2% |
Q3 2021 | $1,283,000 | -16.7% | 45,116 | -1.3% | 0.04% | -16.3% |
Q2 2021 | $1,541,000 | -8.2% | 45,698 | +4.0% | 0.05% | -21.0% |
Q1 2021 | $1,679,000 | +55.2% | 43,947 | +69.9% | 0.06% | +44.2% |
Q4 2020 | $1,082,000 | +252.4% | 25,871 | +265.2% | 0.04% | +207.1% |
Q3 2020 | $307,000 | -2.2% | 7,085 | -31.5% | 0.01% | -17.6% |
Q2 2020 | $314,000 | +139.7% | 10,350 | +8.4% | 0.02% | +88.9% |
Q1 2020 | $131,000 | 0.0% | 9,550 | +17.2% | 0.01% | +28.6% |
Q4 2019 | $131,000 | +59.8% | 8,150 | +132.9% | 0.01% | +40.0% |
Q3 2019 | $82,000 | 0.0% | 3,500 | 0.0% | 0.01% | 0.0% |
Q2 2019 | $82,000 | – | 3,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EMORY UNIVERSITY | 104,861 | $1,560,000 | 2.11% |
Baker Brothers Advisors | 6,554,967 | $97,538,000 | 0.86% |
SECTORAL ASSET MANAGEMENT INC | 929,765 | $13,835,000 | 0.58% |
Camber Capital Management LP | 500,000 | $7,440,000 | 0.51% |
Rock Springs Capital Management LP | 400,000 | $5,952,000 | 0.43% |
Redmile Group, LLC | 181,224 | $2,563,000 | 0.21% |
Perceptive Advisors | 299,583 | $2,306,000 | 0.14% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 166,666 | $2,480,000 | 0.08% |
CORRADO ADVISORS, LLC | 11,860 | $176,000 | 0.08% |
Orbimed Advisors | 456,666 | $6,795,000 | 0.05% |